Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials
Author:
Funder
Natural Science Foundation of China
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference35 articles.
1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur. Urol.,2017
2. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J. Urol.,2017
3. NCCN Clinical Practice Guidelines in Oncology-Bladder Cancer(2017 Version 5)[DB/OL].
4. Is maintenance Bacillus Calmette-Guérin really necessary?;Herr;Eur. Urol.,2008
5. Maintenance therapy with 3-monthly Bacillus calmette-guerin for 3 Years is not superior to standard induction therapy in high-risk non-muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO study 98013;Martinez-Pineiro;Eur. Urol.,2015
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507);BMC Urology;2023-11-24
2. Comparison of Bacillus Calmette-Guérin Maintenance Therapy with Monthly Instillations and the Southwest Oncology Group Protocol in the Treatment of Non–muscle-invasive Bladder Cancer;European Urology Focus;2023-11
3. Prognostic Role of Preoperative Neutrophil-To-Lymphocyte Ratio (NLR) and Recurrence at First Evaluation after Bacillus Calmette–Guérin (BCG) Induction in Non-Muscle-Invasive Bladder Cancer;Diagnostics;2023-10-02
4. Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non‐muscle‐invasive bladder cancer: A retrospective multicenter study;International Journal of Urology;2023-09-04
5. The role of Bacillus Calmette-Guérin administration on the risk of dementia in bladder cancer patients: a systematic review and meta-analysis;Frontiers in Aging Neuroscience;2023-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3